Open access
Oct 2026
Effects of rivaroxaban combined with clopidogrel on thrombotic risk and myocardial injury indicators in patients with coronary artery ectasia.
Objective To investigate the association between rivaroxaban combined with clopidogrel therapy and thrombotic risk, platelet activation, myocardial injury biomarkers, and clinical outcomes in patients with coronary artery ectasia (CAE). Methods This single-center retrospective cohort study included 158 consecutive pa...
Tao Geng, Meng Feng, Yun-Jie Wu et al.
· Frontiers in Cardiovascular... · 0 citations